Latest Period
Q1 2026
CUSIP: 30233G209
Latest Period
Q1 2026
Institutions Reporting
185
Shares (Excl. Options)
88,510,788
Price
$12.89
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 185 institutions filings for Q1 2026.
Security key
30233G209
Latest holder period
Q1 2026
13F holders
185
13D/G owners
8
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 30233G209:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 10% | $99,097,350 | 8,265,000 | Cormorant Asset Management, LP | 04 Dec 2025 | |||
| FEDERATED HERMES, INC. | 6.7% | $43,281,744 | 4,599,450 | Federated Hermes, Inc. | 30 Jun 2025 | |||
| BlackRock, Inc. | 6.5% | $63,872,124 | 4,485,402 | BlackRock, Inc. | 30 Sep 2025 | |||
| FRANKLIN RESOURCES INC | 6.1% | -18% | $27,059,688 | +$820,894 | 4,137,567 | +3.1% | Franklin Resources, Inc. | 31 Dec 2024 |
| TCG Crossover GP II, LLC | 4.3% | $62,265,799 | 3,572,335 | TCG Crossover GP II, LLC | 31 Dec 2025 | |||
| Adage Capital Management, L.P. | 4% | -29% | $46,827,000 | -$19,866,000 | 3,300,000 | -30% | Adage Capital Management, L.P. | 31 Mar 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 4.7% | $20,809,090 | 3,181,818 | RA Capital Management, L.P. | 31 Dec 2024 | |||
| Paradigm Biocapital Advisors LP | 3.8% | -26% | $44,591,181 | -$14,897,003 | 3,142,437 | -25% | Paradigm BioCapital Advisors LP | 31 Mar 2026 |
As of 31 Mar 2026, 185 institutional investors reported holding 88,510,788 shares of EyePoint, Inc. - Common Stock, $0.001 par value per share (EYPT). This represents 107% of the company’s total 82,695,711 outstanding shares.
13F concentration
Largest 13F positions for this security by reported shares and value.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 10% | 8,296,375 | +6% | 2.9% | $106,940,274 |
| Cormorant Asset Management, LP | 10% | 8,265,000 | 0% | 5.4% | $106,535,850 |
| BlackRock, Inc. | 8.7% | 7,177,337 | +5.7% | 0% | $92,515,874 |
| FEDERATED HERMES, INC. | 6.9% | 5,669,589 | -5.8% | 0.12% | $73,081,003 |
| FRANKLIN RESOURCES INC | 6.1% | 5,048,598 | +1.4% | 0.02% | $65,076,424 |
| JANUS HENDERSON GROUP PLC | 4.4% | 3,601,168 | +23% | 0.02% | $46,419,056 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.3% | 3,559,569 | 0% | 0% | $45,882,844 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4% | 3,300,000 | -30% | 0.07% | $42,537,000 |
| Paradigm Biocapital Advisors LP | 3.8% | 3,142,437 | -15% | 0.83% | $40,506,013 |
| Commodore Capital LP | 3.4% | 2,825,000 | 2.1% | $36,414,250 | |
| STATE STREET CORP | 2.5% | 2,097,202 | +14% | 0% | $27,032,934 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4% | 1,983,665 | +4.4% | 0% | $25,573,730 |
| CITADEL ADVISORS LLC | 2.3% | 1,905,875 | 0.02% | $24,566,729 | |
| Aberdeen Group plc | 2.1% | 1,738,378 | +8.2% | 0.04% | $22,407,692 |
| Balyasny Asset Management L.P. | 1.7% | 1,438,737 | +142% | 0.04% | $18,545,320 |
| Parkman Healthcare Partners LLC | 1.6% | 1,354,800 | +25% | 1.8% | $17,463,372 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.5% | 1,245,583 | 0.27% | $16,055,565 | |
| MORGAN STANLEY | 1.3% | 1,096,109 | +390% | 0% | $14,128,844 |
| Essex Woodlands Management, Inc. | 1.3% | 1,084,857 | 0% | 5.6% | $13,983,807 |
| ORBIMED ADVISORS LLC | 1.3% | 1,069,147 | -57% | 0.31% | $13,781,305 |
| 5AM Venture Management, LLC | 1.3% | 1,050,000 | 0% | 3.8% | $13,534,500 |
| Rosalind Advisors, Inc. | 1.3% | 1,036,737 | +50% | 5.5% | $13,363,540 |
| Blue Owl Capital Holdings LP | 1.1% | 912,594 | +132% | 3.2% | $11,763,337 |
| HSBC HOLDINGS PLC | 1% | 833,455 | 0.01% | $10,743,235 | |
| STEMPOINT CAPITAL LP | 0.98% | 810,764 | +129% | 2% | $10,450,748 |
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 88,510,788 | $1,140,946,477 | +$42,505,333 | $12.89 | 185 |
| 2025 Q4 | 83,462,311 | $1,524,932,141 | +$249,855,302 | $18.27 | 165 |
| 2025 Q3 | 69,898,687 | $995,227,037 | +$20,107,476 | $14.24 | 148 |
| 2025 Q2 | 68,912,118 | $648,484,078 | -$21,934,653 | $9.41 | 139 |
| 2025 Q1 | 74,070,140 | $401,203,753 | -$6,558,607 | $5.42 | 149 |
| 2024 Q4 | 74,299,852 | $553,357,101 | +$114,467,368 | $7.45 | 141 |
| 2024 Q3 | 58,498,731 | $476,138,776 | -$4,424,916 | $7.99 | 135 |
| 2024 Q2 | 58,415,381 | $508,206,601 | -$17,769,473 | $8.70 | 148 |
| 2024 Q1 | 55,009,467 | $1,137,046,639 | +$106,318,844 | $20.67 | 161 |
| 2023 Q4 | 49,565,894 | $1,145,491,759 | +$422,510,894 | $23.11 | 138 |
| 2023 Q3 | 33,709,262 | $269,337,991 | +$16,845,118 | $7.99 | 98 |
| 2023 Q2 | 31,573,084 | $274,685,383 | +$22,852,995 | $8.70 | 82 |
| 2023 Q1 | 29,111,970 | $85,592,348 | -$1,206,242 | $2.94 | 66 |
| 2022 Q4 | 29,377,926 | $102,818,972 | -$13,441,865 | $3.50 | 72 |
| 2022 Q3 | 30,106,241 | $238,140,639 | -$883,849 | $7.91 | 82 |
| 2022 Q2 | 30,200,779 | $237,683,742 | -$3,357,027 | $7.87 | 78 |
| 2022 Q1 | 30,440,222 | $369,919,357 | +$7,173,181 | $12.15 | 78 |
| 2021 Q4 | 29,839,293 | $365,363,130 | +$94,551,507 | $12.24 | 83 |
| 2021 Q3 | 22,128,108 | $230,547,815 | +$14,765,407 | $10.42 | 61 |
| 2021 Q2 | 20,739,059 | $186,447,743 | +$7,944,014 | $8.99 | 59 |
| 2021 Q1 | 19,642,118 | $199,571,620 | +$124,369,380 | $10.16 | 58 |
| 2020 Q4 | 7,703,318 | $50,684,935 | +$50,684,935 | $6.58 | 31 |